News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Anthera Pharmaceuticals, Inc. Plans $70 Million IPO


9/16/2009 8:59:59 AM

Bookmark and Share

Bizjournals.com -- A Hayward biotech focused on inflammatory diseases like from cardiovascular disease and lupus filed for one of the first U.S. biotech IPO in two years.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES